B. Riley analyst Mayank Mamtani lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $4 and keeps a Buy rating on the ...
Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.
Centre for Sight offers AI-driven LASIK laser surgery technology for precise vision correction in under ten seconds per eye.
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...
Dry AMD causes diminished vision accompanied by loss of central retinal pigmented epithelium (RPE) cells in individuals aged 55 and older. There are no approved vision-improving treatments for dry ...
The following is a summary of "Radiation decreases bronchial epithelial progenitor function as assessed by organoid formation ...
A common vaginal infection that affects nearly 1 in 3 women worldwide should be reclassified as a sexually transmitte ...
Amgen and AstraZeneca have reported outcomes from the WAYPOINT trial of Tezspire for treating chronic rhinosinusitis with ...
Bacterial vaginosis, which affects nearly 1 in 3 women, should be considered a sexually transmitted disease, according to a ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...